Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

163 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibody.
Itabe H, Yamamoto H, Imanaka T, Shimamura K, Uchiyama H, Kimura J, Sanaka T, Hata Y, Takano T. Itabe H, et al. J Lipid Res. 1996 Jan;37(1):45-53. J Lipid Res. 1996. PMID: 8820101 Free article.
In our previous study, we obtained a novel murine monoclonal antibody against oxidized lipoproteins (Itabe, H. et al. 1994. J. Biol. Chem. 269: 15274-15279). The epitope of this antibody resides in oxidized products of phosphatidylcholine that can form complexes wit …
In our previous study, we obtained a novel murine monoclonal antibody against oxidized lipoproteins (Itabe, H. et al. 1994. J. …
Oxidized phosphatidylcholines that modify proteins. Analysis by monoclonal antibody against oxidized low density lipoprotein.
Itabe H, Yamamoto H, Suzuki M, Kawai Y, Nakagawa Y, Suzuki A, Imanaka T, Takano T. Itabe H, et al. J Biol Chem. 1996 Dec 27;271(52):33208-17. doi: 10.1074/jbc.271.52.33208. J Biol Chem. 1996. PMID: 8969177 Free article.
We have previously developed a murine monoclonal antibody, FOH1a/DLH3, which recognized oxidatively modified lipoproteins as well as foam cells in human atherosclerotic lesions (Itabe, H., Takeshima, E., Iwasaki, H., Kimura, J., Yoshida, Y., Imanaka, T., and …
We have previously developed a murine monoclonal antibody, FOH1a/DLH3, which recognized oxidatively modified lipoproteins as well as foam ce …
Characterization of vitronectins in atherosclerotic lesions.
Mori M, Iwasaki K, Sato R, Komine Y, Itabe H, Imanaka T, Takano T. Mori M, et al. Among authors: itabe h. J Atheroscler Thromb. 1996;3(1):25-31. doi: 10.5551/jat1994.3.25. J Atheroscler Thromb. 1996. PMID: 9225236
163 results